
Swiss multinational Roche’s flu drug baloxavir marboxil significantly sped up recovery time in comparison with placebo, in people at high …

Bayer has announced its intention to axe 227 employees at a manufacturing site in California as part of a push …

A new group, organised under the banner of the Alliance to Protect Medical Innovation, is blaming hospitals and PBM’s for …

American pharma firm Baxter has announced a new partnership with the Mayo Clinic in a bid to establish a “renal …

The European Medicines Agency has confirmed its approval of Eli Lilly’s CDK4/6 inhibitor Verzenio (ademaciclib), it has emerged. The therapy …

Dr Craig Thompson, Chief Executive of Memorial Sloan Kettering Cancer Center (MSKCC), the renowned non-profit treatment and research institution based …

A study of randomised clinical trials, conducted by Canada’s McMaster University and published in the Journal of the American Medical …

A new study has revealed that African-American citizens make up a disproportionately high share of participants in US clinical trials …

In light of continued austerity gripping the NHS, it was uplifting to hear in July that the health service had …

Great news for HIV patients in the UK as Janssen reveals that NHS England will provide critical funding for its …

Novo Nordisk has announced a wave of jobs cuts as part of a global restructure of its $1 billion R&D …

Life expectancy was a key topic this week, as it emerged that growth has stalled and even fallen in areas …

Gilead has announced its intention to undercut itself by releasing generic versions of its blockbuster drugs for the treatment of …

A survey conducted by The Pistoia Alliance, a not-for-profit coalition of life science companies, vendors, publishers and academic groups, has …

Novartis has partnered up with the Global Antibiotic Research & Development Partnership (GARDP) to push for faster development and wider …